GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (ASX:RLT) » Definitions » Cash, Cash Equivalents, Marketable Securities

Renergen (ASX:RLT) Cash, Cash Equivalents, Marketable Securities : A$0.00 Mil (As of Feb. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Renergen Cash, Cash Equivalents, Marketable Securities?

Renergen's quarterly cash, cash equivalents, marketable securities declined from Feb. 2024 (A$37.98 Mil) to Aug. 2024 (A$8.38 Mil) but then stayed the same from Aug. 2024 (A$8.38 Mil) to Feb. 2025 (A$0.00 Mil).

Renergen's annual cash, cash equivalents, marketable securities declined from Feb. 2022 (A$8.72 Mil) to Feb. 2023 (A$4.51 Mil) but then increased from Feb. 2023 (A$4.51 Mil) to Feb. 2024 (A$37.98 Mil).


Renergen Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Renergen's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen Cash, Cash Equivalents, Marketable Securities Chart

Renergen Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only 11.42 8.72 4.51 37.98 -

Renergen Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.51 15.32 37.98 8.38 -

Renergen Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Renergen  (ASX:RLT) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Renergen Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Renergen's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Renergen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (ASX:RLT) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines